| [2023] FWCFB 101 |
| FAIR WORK COMMISSION |
| DECISION |
Fair Work Act 2009
s.604 - Appeal of decisions
Lipa Pharmaceuticals Ltd
v
Mariam Jarouche
(C2023/1492)
| JUSTICE HATCHER, PRESIDENT | SYDNEY, 31 MAY 2023 |
Appeal against decision [2023] FWC 493 of Deputy President Anderson at Adelaide on 28 February 2023 in matter number C2022/7079
Introduction
Lipa Pharmaceuticals Ltd (Lipa) has lodged an appeal, for which permission is required, against a decision of Deputy President Anderson issued on 28 February 2023.[1] The decision concerned a jurisdictional objection made by Lipa in respect of an application made by Dr Mariam Jarouche pursuant to s 365 of the Fair Work Act 2009 (Cth) (FW Act) in which she alleged that she was dismissed from employment with Lipa in contravention of ss 340, 351 and 352 of the FW Act. Lipa contended that Dr Jarouche’s application was not validly made because she had not been dismissed but rather resigned from her employment. In his decision, the Deputy President rejected this contention and, in conjunction with his decision, made an order[2] by which he determined to issue a certificate in accordance with s 368(3)(a) of the FW Act.
Section 365 provides:
365 Application for the FWC to deal with a dismissal dispute
If:
(a)a person has been dismissed; and
(b)the person, or an industrial association that is entitled to represent the industrial interests of the person, alleges that the person was dismissed in contravention of this Part;
the person, or the industrial association, may apply to the FWC for the FWC to deal with the dispute.
In respect of an application made under s 365, s 368(1) of the FW Act requires that the Commission ‘deal’ with dispute other than by arbitration. The statutory note to s 368(1) states, by reference to s 595(2), that the Commission may ‘deal’ with such a dispute by mediation or conciliation, or by making a recommendation or expressing an opinion. Section 368(3)(a) provides that if the FWC is satisfied that all reasonable attempts to resolve the dispute (other than by arbitration) have been, or are likely to be, unsuccessful, then the FWC must issue a certificate to that effect. Once such a certificate has been issued, the applicant is entitled to make a general protections court application subject to the time limitation in s 370(a)(ii), unless the parties have agreed to the Commission arbitrating the dispute pursuant to s 369.
As the Deputy President correctly stated in paragraph [72] of his decision, a valid application under s 365 requires that the relevant dismissal has actually occurred as a matter of jurisdictional fact. It is not sufficient that the applicant has merely alleged that they were dismissed. If there is a contest as to whether the alleged dismissal the subject of the application has occurred, this is an antecedent question which, according to the Federal Court Full Court decision in Coles Supply Chain Pty Ltd v Milford[3] (Milford) ‘must be resolved before the powers conferred…
Keep reading for free
Create a free CaseChat account to read Lipa Pharmaceuticals v Jarouche and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2023] FWCFB 101
- Decision Date
CaseChat Overview and Summary
The court found that the conduct of Mr Tanna, a representative of Lipa Pharmaceuticals, on 29 September 2022 and subsequent days clearly indicated an intention to terminate Dr Jarouche's employment. The court held that Dr Jarouche had no real choice other than to resign, as evidenced by the immediate cessation of her work and departure from the workplace following Mr Tanna's meeting with her. The court further clarified that although the exact terms of the departure were later negotiated, the fundamental decision to end Dr Jarouche's employment had already been made by Lipa Pharmaceuticals on 29 September 2022. The court determined that Dr Jarouche's acceptance of the proposed 'managed resignation' was a response to the already imposed reality of her employment termination.
In light of the findings, the court concluded that Dr Jarouche had been dismissed by Lipa Pharmaceuticals, within the meaning of section 386(1) of the Fair Work Act. This conclusion was based on the jurisdictional fact that Dr Jarouche's employment relationship had effectively ended on Lipa's initiative on 29 September 2022, despite the subsequent negotiations over the terms of her departure. The court upheld the decision of the Deputy President that Dr Jarouche had been dismissed and rejected Lipa's appeal.
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.